In an interview with Bloomberg Businessweek, Bayer CEO Marijn Dekkers said that his company’s new cancer drug, Nexavar, isn’t “for Indians,” but “for western patients who can afford it.” The drug, which is particularly effective on late-…
An economics, investment, trading and policy blog with a focus on Modern Monetary Theory (MMT). We seek the truth, avoid the mainstream and are virulently anti-neoliberalism.
Showing posts with label patent. Show all posts
Showing posts with label patent. Show all posts
Sunday, January 26, 2014
Scott Kaufman — Bayer Pharmaceutical CEO: Cancer drug only ‘for western patients who can afford it’ (via Raw Story )
Friday, March 29, 2013
Timothy Taylor — Is "Intellectual Property" a Misnomer?
If "intellectual property" is not a misnomer, then it needs to be explained on what basis a property right is time-delimited, as are copyrights and patents but not other forms of property. Is this a property right or a subsidy granted by law, e.g., to foster innovation and creativity?
Conservable Economist
Is "Intellectual Property" a Misnomer?
Timothy Taylor
Subscribe to:
Posts (Atom)